Results 101 to 110 of about 2,500 (166)

Trifluoromethylpyridine 1,3,4-Oxadiazole Derivatives: Emerging Scaffolds as Bacterial Agents. [PDF]

ACS Omega, 2021
Yu G, Chen S, Guo S, Xu B, Wu J.
europepmc   +1 more source

Mechanistic and Structural Insights on Difluoromethyl-1,3,4-oxadiazole Inhibitors of HDAC6. [PDF]

Int J Mol Sci
Cellupica E, Gaiassi A, Rocchio I, Rovelli G, Pomarico R, Sandrone G, Caprini G, Cordella P, Cukier C, Fossati G, Marchini M, Bebel A, Airoldi C, Palmioli A, Stevenazzi A, Steinkühler C, Vergani B.   +16 more
europepmc   +1 more source

1,3,4-Oxadiazole-naphthalene hybrids as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative activity, apoptotic effect, and in silico studies. [PDF]

J Enzyme Inhib Med Chem, 2022
Hagras M, Saleh MA, Ezz Eldin RR, Abuelkhir AA, Khidr EG, El-Husseiny AA, El-Mahdy HA, Elkaeed EB, Eissa IH.   +8 more
europepmc   +1 more source

Microwave-Assisted Synthesis and Characterization of Novel 1,3,4-Oxadiazole Derivatives and Evaluation of In Vitro Antimycobacterial Activity. [PDF]

Cureus
Devaraji M, Thanikachalam PV.
europepmc   +1 more source

A combined crystallographic and theoretical investigation of noncovalent interactions in 1,3,4-oxadiazole-2-thione-N-Mannich derivatives: in vitro bioactivity and molecular docking. [PDF]

RSC Adv, 2023
Al-Wahaibi LH, Alagappan K, Gomila RM, Blacque O, Frontera A, Percino MJ, El-Emam AA, Thamotharan S.   +7 more
europepmc   +1 more source

Design, synthesis, and apoptotic antiproliferative efficacy of new quinazoline/1,3,4-oxadiazole-2-thione derived EGFR/HER-2 dual inhibitors with anti-breast cancer activity. [PDF]

RSC Med Chem
Gomaa HAM, Shaker ME, Alzarea SI, Alsahli TG, Alanazi AS, Mohamed FAM, Alanazi MN, Abou-Zied HA, Abdelmoez A, Brase S, Youssif BGM, Maghraby MT.   +11 more
europepmc   +1 more source

1,3,4-Oxadiazole Contained Sesquiterpene Derivatives: Synthesis and Microbiocidal Activity for Plant Disease. [PDF]

Front Chem, 2022
Dai A, Zheng Z, Yu L, Huang Y, Wu J.
europepmc   +1 more source

Retraction notice to "Synthesis, molecular docking study and anticancer activity of novel 1,3,4-oxadiazole derivatives as potential tubulin inhibitors" [Heliyon 9 (2023) e13460]. [PDF]

Heliyon
Yousef TA, Alhamzani AG, Abou-Krisha MM, Kanthimathi G, Raghu MS, Kumar KY, Prashanth MK, Jeon BH.   +7 more
europepmc   +1 more source

Synthesis, molecular docking study and anticancer activity of novel 1,3,4-oxadiazole derivatives as potential tubulin inhibitors.

Heliyon, 2023
Yousef TA, Alhamzani AG, Abou-Krisha MM, Kanthimathi G, Raghu MS, Kumar KY, Prashanth MK, Jeon BH.   +7 more
europepmc   +1 more source